Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma

NCT01721772

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Fundacion Cidea Buenos Aires, Distrito Federal, Argentina
  • Instituto Medico Especialazado Alexander Fleming Buenos Aires, Argentina
  • Instituto Oncologico De Cordoba Córdoba, Argentina
  • Local Institution Camperdown, New South Wales, Australia
View all 75 locations
View Trial Details
Completed

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

NCT02714218

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University Of Colorado Cancer Center Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Allina Health Fridley, Minnesota, United States
  • Washington University School Of Medicine St Louis, Missouri, United States
View all 57 locations
View Trial Details
Completed

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

NCT00130442

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Arizona Cancer Centre Tucson, Arizona, United States
  • University of Colorado Health Science Centre Denver, Colorado, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Sydney Cancer Centre, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View Trial Details
Completed

Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study

NCT02780089

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • Cancer Care Associates Redondo Beach, California, United States
View all 66 locations
View Trial Details
Completed

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

NCT00297895

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Sharp Hospital San Diego, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • Memorial Hospital - Colorado Springs Colorado Springs, Colorado, United States
  • Lakeland Regional Cancer Center Lakeland, Florida, United States
View all 63 locations
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details

Related conditions